Live Event

Hospital Medicine: Management of the Hospitalized Adult Patient

Title:Hospital Medicine: Management of the Hospitalized Adult Patient
Dates:April 1, 2019 8:00 am - April 5, 2019 12:15 pm
Location:Sarasota, Florida
Daily Schedule:8:00am-12:15pm
Course #:SEMLA-3320190401

Certifications

20 AMA PRA Category 1 Credits™
20 CME Credits – AAFP ACEP ACOG
Mainpro-M1 (Canadian Physicians)

PLEASE CLICK HERE TO BOOK YOUR HOTEL ROOM FOR THIS CONFERENCE


Venue

100 Marina View Drive
Sarasota
Florida
34236
United States

We’re excited to welcome event attendees to the Westin Sarasota, the city’s newest luxury accommodations. Gorgeous sunset views from the rooftop pool and bar, nearby white sand beaches and high-end dining just blocks away are waiting for you.Indulge Your Every Sense at Downtown Sarasota’s Premier New Hotel. Surround yourself with contemporary elegance at The Westin Sarasota.

Overlooking Sarasota Bay, in the midst of the vibrant arts district, our brand new hotel features sophisticated touches designed to make your stay exceptional.Take advantage of the ideal downtown setting and complimentary shuttle to explore the city’s best theater, arts and beaches. Just 10 minutes from the Sarasota-Bradenton International Airport (SRQ).

Join us in Sarasota and stay at the Westin using our booking link below and receive: 

  • a 20% discount on services from The Spa & Salon
  • waived $22 per room per day destination fee 
  • reduced valet parking rate of $15 per night

By staying at the host hotel, not only do you save money, but you help us meet our contractual obligations, thereby, allowing us to keep your future hotel room rates and registration fees reasonable.If you have any problems making your reservations with the Westin Sarasota, please contact our office at 866-267-4263 and we will be happy to assist you.


Course Outline

Day 1

Bronchial Asthma: An Update.

Upon the completion of this session using the NAEPP Guidelines, the participant should be able to: GL, COMP

  1. Appraise the pathophysiology of this inflammatory disease.
  2. Develop a stepwise approach to treatment of asthma and management of status asthmaticus.
  3. Differentiate the patient who is not responding and specify indications for subspecialty referral.

Pleural Diseases: Effusions and Pneumothorax.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Determine the etiology of various pleural effusions by means of cases.
  2. Formulate the investigation and management of pleural effusions.
  3. Detect the presentation of pneumothorax.
  4. Develop the clinical approach to management of pneumothorax using the ACCP Delphi Guidelines.

Systolic and Diastolic Heart Failure. 

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Appropriately manage decompensated heart failure in hospitalized patients.
  2. Assess the indications for positive inotropic agents and ultrafiltration in systolic heart failure.
  3. Distinguish the treatment of systolic versus diastolic heart failure, as per the 2013 ACCF/AHA Guidelines for heart failure management.

Atrial Fibrillation in the Hospitalized Patient.

Upon completion of this session, the participant should be able to: COMP, GL

  1. Assess and evaluate treatment options for atrial fibrillation with rapid ventricular response, as per the 2010 HFSA Guidelines.
  2. Employ appropriate anticoagulation strategies for atrial fibrillation.
  3. Distinguish the advantages of rhythm versus rate control treatment strategies, 2014 ACC/AHA Guidelines for atrial fibrillation management.
  4. Determine the possible underlying causes of CHF exacerbations.

Day 2

Challenging Infections: Methicillin Resistant Staphylococcus Aureus, Clostridium difficile.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Assess and apply appropriate treatment strategies for different types of methicillin resistant staph aureus infections, as per the IDSA Guidelines.
  2. Employ rational use and relate the precautions of newer antibiotics when treating resistant bacteria.
  3. Distinguish Guideline based treatment of Clostridium difficile infections, as per the AGA Guidelines.

Consultative Medicine: Transfusion Guidelines, Delirium in the Hospitalized Patient.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Interpret changes in the updated 2012 American College of Chest Physicians Evidence-Based Guidelines for Antithrombotic Therapy.
  2. Assess restrictive red blood cell transfusion strategy as recommended by American Association of Blood Banks (AABB) guidelines.
  3. Evaluate clinical factors that make patients more prone to hospital and postoperative delirium.
  4. Employ evidence-based strategies to treat delirium in hospitalized patients.

Pulmonary Cases for Review – Part I.

Upon the completion of this session, the participant should be able to: GL, COMP

  1. Develop a differential diagnosis and approach to a patient with a non-resolving infiltrate.
  2. Assess the causes and determine the evaluation of solitary lung nodule.
  3. Evaluate idiopathic pulmonary fibrosis and employ current management using the ATS/ERS Guidelines.

Arterial Blood Gas: A Six Step Approach to Rapid Interpretation.

Upon completion of this session, the participant should be able to: COMP

  1. Distinguish and determine the type of acid base disturbance – Acidosis and Alkalosis.
  2. Determine the anion gap and its role in defining and treating acid base disorders.
  3. Assess osmolal gap and urine anion gap.
  4. Develop the management of acid base disorders by a case based discussion.

Day 3

Critical Care Cases for Review – Part I.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Detect acute liver failure (ALF) and develop appropriate plans for management of ALF and acetaminophen OD.
  2. Detect pulmonary edema in the ICU and formulate a plan for the management of ARDS.
  3. Integrate the management of a patient with cardiac arrest based on AHA-ACLS Guidelines with consideration for therapeutic hypothermia and develop a brain death protocol.

Pneumonia.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Differentiate the presentation of various cases of pneumonia and management.
  2. Distinguish the different pathogens that cause pneumonia.
  3. Apply evidence-based recommendations for prevention of pneumococcal pneumonia.
  4. Plan the approach to health care associated pneumonia.

Novel Oral Anticoagulants.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Differentiate the advantages and disadvantages of commonly used anticoagulants.
  2. Employ evidence-based anticoagulation bridging regimens.
  3. Assess the approved indications for various anticoagulation agents.
  4. Apply the evidence-based indications for anticoagulation in hospitalized patients.

Update in Perioperative Medicine.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Appraise pre-operative cardiac risk stratification and management strategies, as per the ACC/AHA Risk Clinical Predictors.
  2. Determine the role of non-invasive stress testing, echocardiography, coronary angiography and the use of biomarkers to assess peri-operative cardiac risk, as per the ACC/AHA (2014) Perioperative CV Evaluation Guidelines.
  3. Relate the indications for beta blockers, statins and aspirin in the peri-operative period.

Evaluate the bleeding risks of commonly prescribed medications and OTC supplements taken pre-operatively.

Day 4

Septic Shock.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Define shock and differentiate the various types of shock.
  2. Develop and apply the concept of sepsis management bundles.
  3. Formulate and manage the early resuscitation of septic shock, vasopressor use and monitoring.
  4. Specify the current controversies in management of septic shock based on SCCM/Survival Sepsis Campaign Guidelines.

Pulmonary Cases for Review – Part II.

Upon completion of this session, the participant should be able to: EBM, GL, COMP

  1. Identify and properly evaluate sleep apnea and excessive daytime sleepiness.
  2. Specify the various causes of hemoptysis and develop an appropriate plan for management.
  3. Apply the evidence-based recommendations of pulmonary embolism including thrombolysis or appropriate referral for vena caval filters.

Approach to the Management of Stroke.

Upon completion of this session, the participant should be able utilize the latest evidence based medicine and guidelines to: EBM, GL, COMP

  1. Develop a strategy to assess the common presentations of stroke/TIA.
  2. Utilize current initial treatment strategies appropriately.
  3. Develop a strategy to stratify the risk of stroke.
  4. Develop a secondary prevention plan.

Approach to the Management of Chest Pain.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Evaluate the complaint in the context of history, physical exam, and EKG findings.
  2. Develop a strategy to use cardiac biomarkers in the evaluation of ACS.

Use recent research studies and guidelines to develop an approach to the patient with chest pain.

Day 5

Approach to the Management of Diabetes in the Hospitalized Patient.

Upon completion of this session, the participant should be able to utilize the latest evidence based medicine and guidelines to: EBM, GL, COMP

  1. Develop a diabetes treatment strategy that identifies and reaches a target glucose.
  2. Develop a diabetes treatment strategy that integrates the issues of chronic management.
  3. Develop a diabetes treatment strategy that utilizes insulin effectively.

Strategies to Address the Issue of Preventable Hospital Readmissions.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Identify the factors which contribute to increase risk of readmission.
  2. Stratify the risk for readmission utilizing evidence-based tools.
  3. Develop a transition of care strategy to reduce the likelihood of a preventable readmission.

COPD – Overview of Patient Management.

Upon the completion of this session, the participant should be able to: GL, COMP

  1. Appraise the definition and integrate the pathophysiology of COPD.
  2. Assess the clinical management of various issues regarding COPD.
  3. Treat acute exacerbations and outpatient management including long-term oxygen and pharmacologic treatment based on ATS/ACCP Guidelines.
  4. Evaluate the need of referral for surgical and newer treatments for emphysema.

Critical Care Cases for Review – Part II.

Upon completion of this session, the participant should be able to: GL, COMP

  1. Detect acute renal failure in the ICU and employ appropriate management using the International Consensus Guidelines.
  2. Detect and assess hypertensive emergencies in the ICU and prescribe appropriate management.

Develop the management of a patient with acute gastro-intestinal bleeding.

Presented By

Presenter

  • David A. Horowitz, M.D. – Perelman School of Medicine at the University of Pennsylvania
  • Vandana Y. Bhide, M.D., F.A.C.P., F.A.A.P., A.B.I.H.M. Mayo School of Graduate Medicine
  • Ganesan Murali, M.D. Lehigh Valley Health Care Network, Allentown
  • Arshad A. Wani, M.D. Perelman School of Medicine, University of Pennsylvania

Fee Structure

To receive the Early Registration Rate, fees must be postmarked >60 days prior to program start date (April 1, 2019 8:00 am).

Register

Details Price Qty
Physician Fees - Early Registration $899.00 (USD)  
Physician Fees - Regular Registration $949.00 (USD)   Goes On Sale
February 1, 2019
Resident Fees - Early Registration $799.00 (USD)  
Resident Fees - Regular Registration $849.00 (USD)   Goes On Sale
February 1, 2019
Advanced Practitioner Fees - Early Registration $749.00 (USD)  
Advanced Practitioner Fees - Regular Registration $799.00 (USD)   Goes On Sale
February 1, 2019
AMS Exception Ticket $899.00 (USD)  

Need help? Have a question?

mail@ams4cme.com 1-866-267-4263 Disclaimer: AMS reserves the right to cancel any conference within 6 weeks of conference date. Registrants will receive a full refund within 7 business days. AMS is not responsible for charges associated with canceled flight or hotel rooms. AMS Cancellation Policy: Although it is rarely necessary, American Medical Seminars, Inc. reserves the right to modify speakers and subject matter. American Medical Seminars, Inc. assumes no liability beyond the refund of the seminar registration fee. In the unlikely event that AMS postpones or cancels this conference due to circumstances beyond our control, you will be provided with a refund for the registration fee or you can opt to transfer to another of our live events.